Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Rapid Assay for Detection of the Epidemiologically Important Central Asian/Russian Strain of the Mycobacterium tuberculosis Beijing Genotype.

Mokrousov I, Chernyaeva E, Vyazovaya A, Skiba Y, Solovieva N, Valcheva V, Levina K, Malakhova N, Jiao WW, Gomes LL, Suffys PN, Kütt M, Aitkhozhina N, Shen AD, Narvskaya O, Zhuravlev V.

J Clin Microbiol. 2018 Jan 24;56(2). pii: e01551-17. doi: 10.1128/JCM.01551-17. Print 2018 Feb. No abstract available.

2.

Emerging resistant clones of Mycobacterium tuberculosis in a spatiotemporal context.

Vyazovaya A, Levina K, Zhuravlev V, Viiklepp P, Kütt M, Mokrousov I.

J Antimicrob Chemother. 2018 Feb 1;73(2):325-331. doi: 10.1093/jac/dkx372.

PMID:
29092043
3.

Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance.

Cegielski JP, Kurbatova E, van der Walt M, Brand J, Ershova J, Tupasi T, Caoili JC, Dalton T, Contreras C, Yagui M, Bayona J, Kvasnovsky C, Leimane V, Kuksa L, Chen MP, Via LE, Hwang SH, Wolfgang M, Volchenkov GV, Somova T, Smith SE, Akksilp S, Wattanaamornkiet W, Kim HJ, Kim CK, Kazennyy BY, Khorosheva T, Kliiman K, Viiklepp P, Jou R, Huang AS, Vasilyeva IA, Demikhova OV; Global PETTS Investigators, Lancaster J, Odendaal R, Diem L, Perez TC, Gler T, Tan K, Bonilla C, Jave O, Asencios L, Yale G, Suarez C, Walker AT, Norvaisha I, Skenders G, Sture I, Riekstina V, Cirule A, Sigman E, Cho SN, Cai Y, Eum S, Lee J, Park S, Jeon D, Shamputa IC, Metchock B, Kuznetsova T, Akksilp R, Sitti W, Inyapong J, Kiryanova EV, Degtyareva I, Nemtsova ES, Levina K, Danilovits M, Kummik T, Lei YC, Huang WL, Erokhin VV, Chernousova LN, Andreevskaya SN, Larionova EE, Smirnova TG.

Clin Infect Dis. 2016 Feb 15;62(4):418-430. doi: 10.1093/cid/civ910. Epub 2015 Oct 27.

4.

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis.

Skripconoka V, Danilovits M, Pehme L, Tomson T, Skenders G, Kummik T, Cirule A, Leimane V, Kurve A, Levina K, Geiter LJ, Manissero D, Wells CD.

Eur Respir J. 2013 Jun;41(6):1393-400. doi: 10.1183/09031936.00125812. Epub 2012 Sep 27.

5.

Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study.

Dalton T, Cegielski P, Akksilp S, Asencios L, Campos Caoili J, Cho SN, Erokhin VV, Ershova J, Gler MT, Kazennyy BY, Kim HJ, Kliiman K, Kurbatova E, Kvasnovsky C, Leimane V, van der Walt M, Via LE, Volchenkov GV, Yagui MA, Kang H; Global PETTS Investigators, Akksilp R, Sitti W, Wattanaamornkiet W, Andreevskaya SN, Chernousova LN, Demikhova OV, Larionova EE, Smirnova TG, Vasilieva IA, Vorobyeva AV, Barry CE 3rd, Cai Y, Shamputa IC, Bayona J, Contreras C, Bonilla C, Jave O, Brand J, Lancaster J, Odendaal R, Chen MP, Diem L, Metchock B, Tan K, Taylor A, Wolfgang M, Cho E, Eum SY, Kwak HK, Lee J, Lee J, Min S, Degtyareva I, Nemtsova ES, Khorosheva T, Kyryanova EV, Egos G, Perez MT, Tupasi T, Hwang SH, Kim CK, Kim SY, Lee HJ, Kuksa L, Norvaisha I, Skenders G, Sture I, Kummik T, Kuznetsova T, Somova T, Levina K, Pariona G, Yale G, Suarez C, Valencia E, Viiklepp P.

Lancet. 2012 Oct 20;380(9851):1406-17. doi: 10.1016/S0140-6736(12)60734-X. Epub 2012 Aug 30. Erratum in: Lancet. 2012 Oct 20;380(9851):1386.

PMID:
22938757
6.

Drug susceptibility testing of Mycobacterium tuberculosis to fluoroquinolones: first experience with a quality control panel in the Nordic-Baltic collaboration.

Johansen IS, Larsen AR, Sandven P, Petrini B, Soini H, Levina K, Sosnovskaja A, Skenders G, Hoffner S.

Int J Tuberc Lung Dis. 2003 Sep;7(9):899-902.

PMID:
12971676
7.

Discordant resistance to kanamycin and amikacin in drug-resistant Mycobacterium tuberculosis.

Krüüner A, Jureen P, Levina K, Ghebremichael S, Hoffner S.

Antimicrob Agents Chemother. 2003 Sep;47(9):2971-3.

8.

Spread of drug-resistant pulmonary tuberculosis in Estonia.

Krüüner A, Hoffner SE, Sillastu H, Danilovits M, Levina K, Svenson SB, Ghebremichael S, Koivula T, Källenius G.

J Clin Microbiol. 2001 Sep;39(9):3339-45.

9.

Clinical outcomes of Estonian patients with primary multidrug-resistant versus drug-susceptible tuberculosis.

Lockman S, Kruuner A, Binkin N, Levina K, Wang Y, Danilovitsh M, Hoffner S, Tappero J.

Clin Infect Dis. 2001 Feb 1;32(3):373-80. Epub 2001 Jan 26.

PMID:
11170944
10.

Present state of tuberculosis in the Czech Republic and in central European and Baltic countries.

Kubín M, Príkazský V, Havelková M, Svandová E, Levina K, Kurve A, Leimans J.

Cent Eur J Public Health. 1999 Aug;7(3):109-15.

PMID:
10499140
11.

Drug resistant tuberculosis in Estonia.

Kruuner A, Sillastu H, Danilovitsh M, Levina K, Svenson SB, Källenius G, Hoffner SE.

Int J Tuberc Lung Dis. 1998 Feb;2(2):130-3.

PMID:
9562123
12.

[Experience with practical use of a complex of 3 nutrient media for culture of Mycobacterium tuberculosis].

Levina KA.

Probl Tuberk. 1988;(6):66-7. Russian. No abstract available.

PMID:
3145498
13.

Electronmicroscopic, cytochemical and immunochemical study of B. anthracis and B. cereus.

Avakyan AA, Pavlova IB, Katz LN, Levina KN.

J Hyg Epidemiol Microbiol Immunol. 1967;11(2):151-9. No abstract available.

PMID:
4239117
14.

Structure and composition of the Bacillus anthracis capsule.

Avakyan AA, Katz LN, Levina KN, Pavlova IB.

J Bacteriol. 1965 Oct;90(4):1082-95.

Supplemental Content

Loading ...
Support Center